Post Market Clinical Follow-up of Dual-mobility Acetabular Cup EUROSCUP MOBILE

N/AActive Not RecruitingNCT04993638

EUROS147 enrolled

Overview

EUROSCUP MOBILE is intended for use in primary and revision total hip replacement surgery. Hip replacement is intended to provide increased patient mobility and reduce pain by replacing the damages hip joint articulation in patients where there is evidence of sufficient sound bone to seat and support the components. As part of post market vigilance, EUROS will collect data on EUROSCUP MOBILE performances and safety

Post market observational study. This study is retropective and prospective, non comparative.

Study Type

OBSERVATIONAL

Enrollment

147

Conditions

Hip Arthropathy Hip Osteoarthritis Hip Arthritis Hip Fractures Hip Necrosis Hip Dysplasia

Interventions

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patient who received EUROSCUP MOBILE. * Patient informed of its participation to the study * Patient aged between 18 and 80 years old (\<80). Exclusion Criteria: * Patient presenting a contraindication to EUROSCUP MOBILE implantation. * Patient who refused to participate to the study * Vulnerable subjects

Locations (3)

Clinique Montagard

Avignon, France

CHU Gabriel Montpied

Clermont-Ferrand, France

Hôpital Saint Joseph-Saint Luc

Lyon, France

Outcomes

Primary Outcomes

Safety of EUROSCUP MOBILE

Collect the safety of the device trought complications occurence rate

Time frame: 1 year

Secondary Outcomes

Radiological performances of EUROSCUP MOBILE

Collect the performances of the device trought radiological evaluation

Time frame: 1 year

Clinical performances of EUROSCUP MOBILE

Collect the performances of the device trought clinical scores

Time frame: 1 year

Survival of EUROSCUP MOBILE

Assess the survival rate of the device

Time frame: 10 year